Issues
Vol. 1 (No. 1) 2021 March
Cancer research and care in the future post-COVID-19 era
A. Giordano, C. Pinto, F. Pentimalli
p.p. 4-6
doi: 10.48286/aro.2021.01
Clinical research during COVID-19 spread: managing an emergency within a pandemic outbreak
C. Cagnazzo, S. Testoni, R. Cenna, S. Stabile, E. Tirtei, N. Bertorello, F. Fagioli
p.p. 7-12
doi: 10.48286/aro.2021.02
Researchers’ Pyramid. A new opportunity for Italian oncology research infrastructure?
S. Testoni, R. Cenna, A.S.E. Guarrera, M. Monti, S. Stabile, I. Federici, C. Taverniti, S. Pirondi, A. Ferrari, C. Cagnazzo
p.p. 13-23
doi: 10.48286/aro.2021.03
EGFR+ Glioblastoma stem cells targeting by CD16158V-chimeric receptor T cells and cetuximab
C. Cenciarelli, S. Caratelli, R. Arriga, G. Lanzilli, A. Ottaviani, T. Sconocchia, G. C. Spagnoli, A. Venditti, G. Iezzi, M. Roselli, D. Lauro, H. E. Marei, G. Sconocchia
p.p. 24-35
doi: 10.48286/aro.2021.04
The impact of COVID-19 on new cancer diagnoses
L. Mangone, P. Giorgi Rossi, I. Bisceglia, R. Grilli, C. Pinto
p.p. 36-42
doi: 10.48286/aro.2021.05
Prevention of oxaliplatin-induced peripheral neuropathy in colorectal cancer: the planet trial experience
S. Delfanti, R. Tancredi, F. Serra, T. Monaco, C. Gandini, A. Ferrari, C. Tinelli, S. Brugnatelli
p.p. 43-55
doi: 10.48286/aro.2021.06
The resilience of oncologists during the early time of the COVID-19 pandemic
A. Lasagna, S. Secondino, F. Agustoni, T. Monaco, I. Imarisio, A. Pagani, G. Rizzo, R. J. Tancredi, E. Pozzi, E. Ferraris, S. Chiellino, C. Gandini, A. Ferrari, S. G. Brugnatelli, P. Pedrazzoli
p.p. 56-61
doi: 10.48286/aro.2021.07
Impact of different dosing strategies of nivolumab in patients with solid tumors: Italian single center analysis
T. Gamba, A. Caglio, F. Sacchi, C. Paratore, G. Fazzina, V. Tagini, M. Bellero, S. Masucci, F. Vignani, G. Lacidogna, C. Zichi, G. Aimar, D. Marino, E. Sperti, A. Gasco, M. Di Maio
p.p. 62-71
doi: 10.48286/aro.2021.08
Safety matters: the troubled and finally successful story of dihydropyrimidine dehydrogenase pharmacogenetic test in cancer patients
S. Crucitta, F. Sciandra, A. Cerbioni, F. Cucchiara, R. Arici, C. Rafaniello, A. Capuano, R. van Schaik, R. Danesi, M. Del Re
p.p. 72-85
doi: 10.48286/aro.2021.09
Combination immunotherapy in metastatic renal cell carcinoma
P. Sepe, A. Ottini, E. Verzoni, V. Guadalupi, M. Claps, G. Procopio
p.p. 86-94
doi: 10.48286/aro.2021.10
